Valuation: DexCom, Inc.

Market Cap 27.93B 24.44B 22.52B 20.88B 39.63B 2,651B 40.27B 270B 105B 1,308B 105B 103B 4,522B P/E 2026 *
29.6x
P/E 2027 * 24.8x
Enterprise Value 27.52B 24.09B 22.2B 20.58B 39.06B 2,612B 39.69B 266B 104B 1,289B 103B 101B 4,456B EV / Sales 2026 *
5.27x
EV / Sales 2027 * 4.59x
Free-Float
93.34%
Yield 2026 *
-
Yield 2027 * -
1 day+1.28%
1 week+9.24%
Current month+9.24%
1 month-3.98%
3 months+16.57%
6 months+4.95%
Current year+10.85%
1 week 67.87
Extreme 67.87
73.97
1 month 67.3
Extreme 67.3
78.91
Current year 56.72
Extreme 56.72
78.91
1 year 54.11
Extreme 54.11
89.98
3 years 54.11
Extreme 54.11
142
5 years 54.11
Extreme 54.11
164.86
10 years 10.66
Extreme 10.655
164.86
Manager TitleAgeSince
Chief Executive Officer 47 01/01/2026
Director of Finance/CFO 46 19/03/2021
Chief Tech/Sci/R&D Officer - 01/05/2024
Director TitleAgeSince
Chairman 68 30/07/2018
Director/Board Member 67 20/11/2009
Director/Board Member 47 01/01/2026
Date Insider Type Main position Quantity % Market Cap.
06-15Sell

General Counsel

-1,700 0.0004%
06-15Sell

Director

-4,000 0.0010%
06-04Sell

Executive/Senior Manager

-4,911 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
+1.64%+9.24%-11.30%-41.94% 27.93B
+0.22%+5.62%-28.32%-9.88% 167B
+0.93%+7.16%-4.38%-2.40% 106B
+1.99%+7.60%+0.65%+59.53% 58.09B
+0.27%-0.62%+54.16%+57.62% 52.7B
+0.49%+3.28%-9.63%-39.16% 42.86B
+0.61%+9.05% - - 36.15B
-0.44%-0.81%+60.77%-4.18% 25.27B
+0.99%+2.29%-7.68%-1.13% 20.79B
+1.33%+3.43%-6.33%+5.88% 20.84B
Average +0.82%+2.74%+5.33%+2.70% 55.75B
Weighted average by Cap. +0.82%+2.74%-3.40%+3.33%

Financials

2026 *2027 *
Net sales 5.22B 4.57B 4.21B 3.91B 7.41B 496B 7.53B 50.53B 19.65B 245B 19.62B 19.19B 846B 5.83B 5.1B 4.7B 4.35B 8.27B 553B 8.4B 56.34B 21.91B 273B 21.87B 21.4B 943B
Net income 963M 842M 776M 720M 1.37B 91.36B 1.39B 9.31B 3.62B 45.09B 3.61B 3.54B 156B 1.16B 1.01B 934M 865M 1.64B 110B 1.67B 11.2B 4.35B 54.23B 4.35B 4.25B 187B
Net Debt -405M -354M -327M -303M -575M -38.44B -584M -3.92B -1.52B -18.97B -1.52B -1.49B -65.57B -1.21B -1.06B -977M -905M -1.72B -115B -1.75B -11.71B -4.56B -56.74B -4.55B -4.45B -196B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
07/07/26 $73.57 +1.64% 5,569,088
06/07/26 $72.38 +1.59% 4,621,632
02/07/26 $71.25 +3.47% 3,299,278
01/07/26 $68.86 +2.24% 4,793,643
30/06/26 $67.35 -3.76% 4,300,556
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
72.38USD
Average target price
85.24USD
Spread / Average Target
+17.77%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DXCM Stock